Cargando…

Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England

The UK prioritised delivery of the first dose of BNT162b2 (Pfizer/BioNTech) and AZD1222 (AstraZeneca) vaccines by extending the interval between doses up to 12 weeks. In 750 participants aged 50–89 years, we here compare serological responses after BNT162b2 and AZD1222 vaccination with varying dose...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amirthalingam, Gayatri, Bernal, Jamie Lopez, Andrews, Nick J., Whitaker, Heather, Gower, Charlotte, Stowe, Julia, Tessier, Elise, Subbarao, Sathyavani, Ireland, Georgina, Baawuah, Frances, Linley, Ezra, Warrener, Lenesha, O’Brien, Michelle, Whillock, Corinne, Moss, Paul, Ladhani, Shamez N., Brown, Kevin E., Ramsay, Mary E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664823/ https://www.ncbi.nlm.nih.gov/pubmed/34893611 http://dx.doi.org/10.1038/s41467-021-27410-5

Ejemplares similares

Author Correction: Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
por: Amirthalingam, Gayatri, et al.
Publicado: (2022)

Serological responses to COVID-19 Comirnaty booster vaccine, London, United Kingdom, September to December 2021
por: Ireland, Georgina, et al.
Publicado: (2022)

Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in England
por: Westrop, Samantha J, et al.
Publicado: (2022)

Robust antibody responses in 70–80-year-olds 3 weeks after the first or second doses of Pfizer/BioNTech COVID-19 vaccine, United Kingdom, January to February 2021
por: Subbarao, Sathyavani, et al.
Publicado: (2021)

Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the delta wave and vaccination
por: Oeser, Clarissa, et al.
Publicado: (2022)

Antibody Persistence After Primary SARS-CoV-2 Infection and Protection Against Future Variants Including Omicron in Adolescents: National, Prospective Cohort Study
por: Aiano, Felicity, et al.
Publicado: (2023)

Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, England
por: Vusirikala, Amoolya, et al.
Publicado: (2021)

Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: Active prospective surveillance, December 2020 to March 2021, England
por: Ladhani, Shamez N., et al.
Publicado: (2021)

Emergence of the delta variant and risk of SARS-CoV-2 infection in secondary school students and staff: Prospective surveillance in 18 schools, England
por: Ladhani, Shamez N., et al.
Publicado: (2022)

Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines
por: Andrews, Nick, et al.
Publicado: (2022)

Trends in laboratory-confirmed bacterial meningitis (2012–2019): national observational study, England
por: Subbarao, Sathyavani, et al.
Publicado: (2023)

Effectiveness of BNT162b2 and ChAdOx-1 vaccines in residents of long-term care facilities in England using a time-varying proportional hazards model
por: Paranthaman, Karthik, et al.
Publicado: (2022)

Invasive Meningococcal Disease, 2011–2020, and Impact of the COVID-19 Pandemic, England
por: Subbarao, Sathyavani, et al.
Publicado: (2021)

Impact of Extending the Timing of Maternal Pertussis Vaccination on Hospitalized Infant Pertussis in England, 2014–2018
por: Tessier, Elise, et al.
Publicado: (2020)

SARS-CoV-2 infection and transmission in primary schools in England in June–December, 2020 (sKIDs): an active, prospective surveillance study
por: Ladhani, Shamez N, et al.
Publicado: (2021)

Following the Omicron wave, the majority of children in England have evidence of previous COVID infection
por: Oeser, C, et al.
Publicado: (2023)

Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16
por: Findlow, Helen, et al.
Publicado: (2019)

SARS-CoV-2 infection, antibody positivity and seroconversion rates in staff and students following full reopening of secondary schools in England: A prospective cohort study, September–December 2020
por: Ladhani, Shamez N., et al.
Publicado: (2021)

Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination, March−June 2021, England
por: Powell, Annabel A, et al.
Publicado: (2021)

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
por: Lopez Bernal, Jamie, et al.
Publicado: (2021)

Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021–March, 2022: a national, observational, test-negative, case-control study
por: Powell, Annabel A, et al.
Publicado: (2023)

Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers
por: Harris, Ross J., et al.
Publicado: (2021)

Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021
por: Whitaker, Heather J, et al.
Publicado: (2021)

Antibody persistence and neutralising activity in primary school students and staff: Prospective active surveillance, June to December 2020, England
por: Ireland, Georgina, et al.
Publicado: (2021)

mRNA or ChAd0x1 COVID-19 Vaccination of Adolescents Induces Robust Antibody and Cellular Responses With Continued Recognition of Omicron Following mRNA-1273
por: Dowell, Alexander C., et al.
Publicado: (2022)

Perceptions of adolescents on the COVID-19 pandemic and returning to school: qualitative questionnaire survey, September 2020, England
por: Powell, Annabel A., et al.
Publicado: (2022)

Validity of a reported history of chickenpox in targeting varicella vaccination at susceptible adolescents in England()
por: Field, Nigel, et al.
Publicado: (2014)

COVID-19 vaccination for children aged 5–11 years
por: Ladhani, Shamez N
Publicado: (2022)

Impact of the herpes zoster vaccination programme on hospitalised and general practice consulted herpes zoster in the 5 years after its introduction in England: a population-based study
por: Andrews, Nick, et al.
Publicado: (2020)

Investigation of a pertussis outbreak and comparison of two acellular booster pertussis vaccines in a junior school in South East England, 2019
por: Tessier, Elise, et al.
Publicado: (2021)

COVID-19 vaccine given to children with comorbidities in England, December 2020–June 2021
por: Aiano, Felicity, et al.
Publicado: (2022)

Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England
por: Andrews, Nick, et al.
Publicado: (2022)

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
por: Andrews, Nick, et al.
Publicado: (2022)

Crossing the Rubicon: A fine line between waiting and vaccinating adolescents against COVID-19
por: Ladhani, Shamez N
Publicado: (2021)

Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015–2016
por: Campbell, Helen, et al.
Publicado: (2017)

Association of Spike-Specific T Cells With Relative Protection From Subsequent SARS-CoV-2 Omicron Infection in Young Children
por: Dowell, Alexander C., et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 among Blood Donors and Changes after Introduction of Public Health and Social Measures, London, UK
por: Amirthalingam, Gayatri, et al.
Publicado: (2021)

Enter B and W: two new meningococcal vaccine programmes launched
por: Ladhani, Shamez N, et al.
Publicado: (2016)

SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements
por: Hoschler, Katja, et al.
Publicado: (2022)

Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection
por: Zuo, Jianmin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kpqlrlmenf3ql4pvcb682ta0q2